Biotechnology
Healthcare
Investing News
Market News
Technology
The Market Buzz
Aptorum Group Obtains Clearance from Health Canada to Begin Phase 1 Clinical Trial for ALS-4, Small Molecule Drug for Infections Due to Staphylococcus Aureus
Aptorum Group Limited (NASDAQ: APM) receives clearance from the Public Health Agency of Canada in regards to its Clinical Trial Application to begin Phase 1 study of ALS-4, its...